Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 231 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2784 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METOPROLOL 25MG TABLET Resolved 2024-01-05 2024-03-22 215233
APO-CARVEDILOL 25MG TABLET Actual shortage 2024-01-12 2024-01-12 215952
APO-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2024-01-12 2024-03-01 215964
APO-HYDRALAZINE 25MG TABLET TABLET Resolved 2024-01-19 2024-04-05 216650
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216699
APO-PREGABALIN 25MG CAPSULE Actual shortage 2024-01-19 2024-05-08 216732
ANAFRANIL 25MG TABLET Resolved 2024-03-15 2024-03-22 222473
APO-SERTRALINE 25MG CAPSULE Resolved 2024-03-15 2024-05-03 222481
APO-SITAGLIPTIN MALATE 25MG TABLET Actual shortage 2024-04-12 2024-04-12 224977
APO-SITAGLIPTIN MALATE 25MG TABLET Actual shortage 2024-05-10 2024-05-10 227717
APO-NAPRO-NA 275MG TABLET Resolved 2018-05-15 2018-10-05 49499
APO-NAPRO-NA 275MG TABLET Resolved 2022-06-06 2022-08-22 162077
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-11-03 16938
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-07-17 69918
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-05 2021-02-16 133382
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-16 2021-09-27 137581
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831

Showing 1641 to 1660 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMOXI SUGAR FREE 125MG POWDER FOR SUSPENSION Discontinued 2018-09-07 2018-09-15 60249
APO NAPROXEN TAB 125MG 125MG TABLET Discontinued 2018-09-08 2019-08-08 60663
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-SULIN TAB 150MG 150mg tablet Discontinued 2017-03-13 2017-03-13 1186
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-CLINDAMYCIN 150MG CAPSULE Discontinued 2019-11-11 2019-11-11 98363
APO-OXAZEPAM 15MG TABLET To be discontinued 2018-09-08 2018-09-08 60678
APO-TEMAZEPAM 15MG CAPSULE Discontinued 2018-10-23 2019-01-14 65477
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574
APO-SOTALOL 160MG TABLET Discontinued 2017-03-31 2018-02-05 4971
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316

Showing 121 to 140 of 356